Who
Peter C. Farrell
Director
Company insider
Files Form 4 as: Chairman of the Board, ResMed; Director, Arcturus Therapeutics Holdings; Director, Evolus; Director, Nuvasive.
In numbers
- Trades disclosed
- 501
- Buys
- 4
- Sells
- 130
- Bought
- $291K
- Sold
- $187.3M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 3 Feb 2006
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $228K970 at $234.73 | filing |
| 2 Sep 2026filed 4 Sep 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $228K970 at $234.73 | filing |
| 5 Aug 2026filed 6 Aug 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $1.8M8,000 at $225.00 | filing |
| 5 Aug 2026filed 6 Aug 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $1.8M8,000 at $225.00 | filing |
| 5 Jun 2026filed 15 Jun 2026 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Jun 2026filed 15 Jun 2026 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $450K2,000 at $225.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $450K2,000 at $225.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $520K2,000 at $260.22 | filing |
| 4 Mar 2026filed 5 Mar 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $520K2,000 at $260.22 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $503K2,000 at $251.31 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $503K2,000 at $251.31 | filing |
| 7 Jan 2026filed 9 Jan 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $498K2,000 at $248.83 | filing |
| 7 Jan 2026filed 9 Jan 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $498K2,000 at $248.83 | filing |
| 3 Dec 2025filed 4 Dec 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $503K2,000 at $251.47 | filing |
| 24 Nov 2025filed 26 Nov 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code A | $333K1,331 at $250.52 | filing |
| 20 Nov 2025filed 24 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —536 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,442 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $1.2M11,442 at $101.64 | filing |
| 14 Nov 2025filed 18 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code F | $1.8M7,314 at $244.46 | filing |
The newest 500 lines are listed; the numbers count every line.
News
No headline names them, or the companies they trade most, lately.